Chinese COVID-19 antibody up-and-comer shows guarantee in animal tests Kumar Jeetendra | July 24, 2020 Animal tests of an expected COVID-19 vaccine being developed by Chinese researchers demonstrate it triggers an immune reaction against the novel coronavirus, offering some promise since it goes into early-stage human trials, according to a peer-reviewed study. ARCoV is a messenger RNA vaccine which uses technology like applicants being manufactured by Moderna and BioNtech and …
Chinese COVID-19 immunization competitor shows guarantee in human preliminary: Study Kumar Jeetendra | October 16, 2020 One of China’s leading COVID-19 vaccine candidates, called BBIBP-CorV, was proven to be safe and elicited immune response in a small early-phase human trial, researchers said on Friday. A previous clinical trial reported similar results for a different vaccine that’s also based on inactivated whole SARS-CoV-2 virus, but in that study the vaccine was only …
EMA opens audit of China’s Sinovac Covid jab Kumar Jeetendra | May 4, 2021 The European Medicines Agency said Tuesday it has started a “rolling review” of China’s Sinovac coronavirus jab, a process that could lead to eventual approval for the European market. Made by Sinovac’s Beijing-based Life Sciences unit, the vaccine contains an inactivated coronavirus that cannot cause a disease, but helps a person to develop antibodies against …
